Plain-English translation of NCT04679584 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
COVIDOM is a large research study following up to 2,000 people who have been infected with COVID-19 to learn what happens to their health long-term. Researchers want to understand whether COVID-19 causes lasting damage to different organs — like the lungs, heart, brain, and liver — even in people who had mild illness. The study will also look at how the pandemic itself and pandemic-related changes to daily life may have affected people's overall health and well-being.
COVID-19 is still relatively new, and doctors don't yet fully understand what long-term problems it may cause, especially in people who weren't severely ill at first. This study exists to fill that gap — to find out which organs may be affected long-term and to help doctors better support COVID-19 survivors.
You likely qualify if…
You likely don't qualify if…
If you join, you'll receive a detailed health check-up that includes tests of your lungs, heart, brain function (including smell and taste), and liver. You'll also answer questions about your medical history and your emotional and mental health. Blood and other biological samples will be collected for research. Depending on which part of the study you're enrolled in, you may have varying levels of testing — from basic health assessments to more in-depth examinations — but all participants share their information with the research team to help build a better understanding of COVID-19's long-term effects.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Germany